The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
Por
/ julho 29, 2025 
